Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Pharma Guide

Delpharm Consultants Pty Limited

Delpharm Consultants is one of Australia's leading independent consultancies focusing on pharmaceutical development and related regulatory issues.

Since 1994 we have been providing high quality consultancy and impartial advice to members of the pharmaceutical and biotechnology industries, including advice in areas such as:


Clinical Trial Design and Management;
Regulatory Management Services;
Commercialisation;
GCP Compliance Audits; and
Data Reduction and Final Reports.

Our experienced consultants have held senior positions in the pharmaceutical industry and have considerable expertise in the areas of contract and academic research.

Address: Suites 211 & 212, 5 Alexander St
State: NSW
Suburb: Crows Nest
Postcode: 2065

Phone: (02) 9966-8622
Fax: (02) 9966-9244
Email: delphar@bigpond.net.au
Web address: www.delpharm.com.au

Perspective
Whither the GBMA in a biosim dominated market?
The departure of Belinda Wood from the helm of the GBMA presents an opportunity to consider what role this group can play in the future Australian medicines market.
Approvals Action
New heart pain drug registered
Menarini has registered a new heart pain drug while Sanofi continues to add to Clexane options to address its impending patent expiry.
Pipeline Monitor
Gilead scores first win from Kite buyout
Gilead has received its first FDA approval for newly acquired CAR-T Yescarta following its USD12 billion buyout of original sponsor Kite Pharma in August.